Report16 September 2020
Access Observatory Releases 2020 Annual Report
In September 2020, the Access Observatory released its annual report, “Demonstrating Commitment to Impact Through Measurement and Reporting.” Designed and managed by Boston University, the Access Observatory is an independent reporting platform for private sector-led access programs. By sharing their program information and data with the Access Observatory, Access Accelerated member companies and partners demonstrate their commitment to continuous learning, rigorous measurement and transparency.
As explained in the preface by AXA Investment Managers’ Yo Takatsuki, this annual report provides an “in-depth analysis of the industry-led access to medicine programmes. It reveals the innovative practices undertaken by companies to meaningfully move the dial in low and middle-income countries. The analysis shows evidence of what works and what doesn’t.”
In 2019 alone, 17 new programs were registered in the Access Observatory, most of which were newly created:
- By the end of the year, 75 active access programs operating in 114 countries were registered in the Access Observatory.
- Cancer was the most common disease focus (63%), followed by diabetes (19%) and cardiovascular disease (16%).
- Kenya continues to have the greatest number of active programs with 28, following by India and Tanzania with 14 and South Africa with 13.
The 2020 report also highlights how Access Observatory’s standardized approach supports the identification of synergies, redundancies and gaps in investments for global access, and in turn, lays the groundwork for new multi-company collaborations. In addition, the report shares how several companies have significantly increased internal capacity to measure and report on their access programs and revised agreements with implementing partners to require collection and reporting of program data. Through the Access Observatory, Access Accelerated member companies and partners are able to put their commitment to transparency into practice while charting the course forward for more effective and sustainable programming.
“The achievements and opportunities highlighted by the third annual Access Observatory report are fundamental as Access Accelerated embarks on our fourth year and as the global community faces unprecedented public health challenges,” says Access Accelerated Director James Headen Pfitzer. “This measurement framework allows the private sector to quantitatively demonstrate the impact of our programs during a time where people living with NCDs face greater vulnerability than ever before. We thank our member companies and partners for their submissions to the Access Observatory and their ongoing commitment to transparency.”
Data submitted to the Access Observatory not only captures collective progress in advancing NCD prevention, treatment and care, but it is also now used by the Access to Medicines Foundation in determining their Index rankings.
For more information on the new report and milestones from the first three years of the Access Observatory, visit the Access Observatory website.
IFPMA renounces any liability or responsibility for any damages of any nature whatsoever resulting from the use of, inability to use, and/or reliance on the material and information contained on our website. IFPMA makes no representations or warranties as to the completeness or accuracy of any of the information available on the website as well as does not provide any warranties regarding the security of the content of our website or any linked websites. IFPMA endeavours to make its best effort to keep the information accurate and updated on a regular basis, however this is not claimed to be exhaustive. IFPMA does not guarantee that the website is continuously available and error-free at all times.
We constantly analyse our website logs to improve the value of our website. We do not use this analysis to record or track any personally identifiable information of our visitors. If you are asked to provide personal information such as your name, e-mail or/and postal address when requesting information, providing feedback, registering to a newsletter, or using any other functions of the website, be assured that all such information is considered by IFPMA both private and secure. IFPMA does not share or sell your personal information to third parties. Under no circumstance will details be disclosed publicly, except in order to comply with any legal obligation. This policy reiterates that IFPMA fully appreciates the importance of online privacy and is committed to protecting your personal information.
To enable IFPMA to process any order or registration to an event, a secure online payment system may be used to process payments using credit card details. IFPMA will not be collecting or storing credit card details in our system.
Some of our web pages utilise “cookies”. A “cookie” is a small text file that may be used, for example, to collect information about web site activity. Some cookies and other technologies may serve to recall Personal Information previously indicated by a web user. Most browsers allow you to control cookies, including whether or not to accept them and how to remove them.
Some cookies are necessary for the operation of our website, if you choose to block them some aspects of the site may not work for you. Non necessary cookies are only set when you have given your explicit consent to their use. Such cookies included those set by our statistics package Google Analytics.
We are committed to privacy and support current industry initiatives to preserve individual privacy rights on the Internet. Protecting your privacy on-line is an evolving area and this website will constantly evolve to meet these demands.